These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10887969)

  • 1. Factors involved in the absence of sedative effects by the second-generation antihistamines.
    Timmerman H
    Allergy; 2000; 55 Suppl 60():5-10. PubMed ID: 10887969
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular determinants responsible for sedative and non-sedative properties of histamine H₁-receptor antagonists.
    Uesawa Y; Hishinuma S; Shoji M
    J Pharmacol Sci; 2014; 124(2):160-8. PubMed ID: 24476926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic profile of second-generation antihistamines.
    Nicolas JM
    Allergy; 2000; 55 Suppl 60():46-52. PubMed ID: 10887976
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between occupation of cerebral H1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine.
    Rose C; Quach TT; Llorens C; Schwartz JC
    Arzneimittelforschung; 1982; 32(9a):1171-3. PubMed ID: 6129863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are antihistamines sedative via a blockade of brain H1 receptors?
    Uzan A; Le Fur G; Malgouris C
    J Pharm Pharmacol; 1979 Oct; 31(10):701-2. PubMed ID: 41044
    [No Abstract]   [Full Text] [Related]  

  • 6. Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography.
    Zhang D; Tashiro M; Shibuya K; Okamura N; Funaki Y; Yoshikawa T; Kato M; Yanai K
    J Clin Psychopharmacol; 2010 Dec; 30(6):694-701. PubMed ID: 21105284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The advantages for an H1 antihistamine of a low volume of distribution.
    Tillement JP
    Allergy; 2000; 55 Suppl 60():17-21. PubMed ID: 10887971
    [No Abstract]   [Full Text] [Related]  

  • 8. Positron emission tomography evaluation of sedative properties of antihistamines.
    Yanai K; Zhang D; Tashiro M; Yoshikawa T; Naganuma F; Harada R; Nakamura T; Shibuya K; Okamura N
    Expert Opin Drug Saf; 2011 Jul; 10(4):613-22. PubMed ID: 21521134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines.
    Chishty M; Reichel A; Siva J; Abbott NJ; Begley DJ
    J Drug Target; 2001 Jun; 9(3):223-8. PubMed ID: 11697207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular imaging of histamine receptors in the human brain].
    Tashiro M; Yanai K
    Brain Nerve; 2007 Mar; 59(3):221-31. PubMed ID: 17370648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of first- and second-generation histamine-H1-receptor antagonists on the pentobarbital-induced loss of the righting reflex in streptozotocin-induced diabetic mice.
    Kamei J; Hirano S; Miyata S; Saitoh A; Onodera K
    J Pharmacol Sci; 2005 Feb; 97(2):266-72. PubMed ID: 15699576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsedating antihistamines should be preferred over sedating antihistamines in patients who drive.
    Hennessy S; Strom BL
    Ann Intern Med; 2000 Mar; 132(5):405-7. PubMed ID: 10691592
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonsedating antihistamines: pharmacology, clinical efficacy and adverse effects.
    Kaliner MA
    Am Fam Physician; 1992 Mar; 45(3):1337-42. PubMed ID: 1347437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic index of H1-antihistamines: example of cetirizine.
    Rihoux JP
    Ann Allergy Asthma Immunol; 1999 Nov; 83(5):489-92. PubMed ID: 10582736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging safety issues regarding long-term usage of H(1)receptor antagonists.
    Walsh GM
    Expert Opin Drug Saf; 2002 Sep; 1(3):225-35. PubMed ID: 12904138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihistamines in dermatology.
    Greaves MW
    Skin Pharmacol Physiol; 2005; 18(5):220-9. PubMed ID: 16015020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why are second-generation H1-antihistamines minimally sedating?
    Hu Y; Sieck DE; Hsu WH
    Eur J Pharmacol; 2015 Oct; 765():100-6. PubMed ID: 26291661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists.
    Chen C; Hanson E; Watson JW; Lee JS
    Drug Metab Dispos; 2003 Mar; 31(3):312-8. PubMed ID: 12584158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The real-world risk of taking sedating antihistamines.
    Weiler JM
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):224-5. PubMed ID: 12269640
    [No Abstract]   [Full Text] [Related]  

  • 20. H2 antihistamines (cimetidine) and allergic-inflammatory reactions.
    Norn S; Permin H; Skov PS
    Allergy; 1980 Jun; 35(4):357-61. PubMed ID: 6160781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.